Effectiveness of cerebral embolic protection during transcatheter aortic valve replacement: A systematic review and meta-analysis of randomized trials
CEP devices do not significantly reduce short-term stroke or major complications after TAVR. However, given the prevalence of silent cerebral ischemia, further studies are needed to assess long-term neurological outcomes and identify high-risk subgroups who may benefit.
Authors
- Marco Barbanti (ORCID: https://orcid.org/0000-0002-4903-5437)
- Andrea Marrone (ORCID: https://orcid.org/0000-0002-4408-0271)
- Giampiero Vizzari (ORCID: https://orcid.org/0000-0002-7672-2291)
- Giulia Laterra (ORCID: https://orcid.org/0000-0001-8932-9045)
- Silvia Moscardelli (ORCID: https://orcid.org/0000-0002-8389-7575)
- Alfonso Ielasi (ORCID: https://orcid.org/0000-0002-5982-1669)
- Giampaolo Vetta (ORCID: https://orcid.org/0000-0002-1120-0492)
- Antonio Parlavecchio (ORCID: https://orcid.org/0000-0002-7122-6053)
- Antonio Micari
- Domenico Giovanni Della Rocca (ORCID: https://orcid.org/0000-0003-3837-3462)
- Rodolfo Caminiti (ORCID: https://orcid.org/0000-0003-2779-0818)
- Maurizio Tespili
Institutions
- University of Messina (IT)
- Vrije Universiteit Brussel (BE)
- Università degli Studi di Enna Kore (IT)
- Universitair Ziekenhuis Brussel (BE)
- Ospedali Riuniti Umberto I (IT)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101842
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39